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Abstract
Larvae of the cestodes Taenia solium and Taenia crassiceps infect the central nervous sys-
tem of humans. Taenia solium larvae in the brain cause neurocysticercosis, the leading
cause of adult-acquired epilepsy worldwide. Relatively little is understood about how ces-
tode-derived products modulate host neural and immune signalling. Acetylcholinesterases,
a class of enzyme that breaks down acetylcholine, are produced by a host of parasitic
worms to aid their survival in the host. Acetylcholine is an important signalling molecule in
both the human nervous and immune systems, with powerful modulatory effects on the
excitability of cortical networks. Therefore, it is important to establish whether cestode
derived acetylcholinesterases may alter host neuronal cholinergic signalling. Here we make
use of multiple techniques to profile acetylcholinesterase activity in different extracts of both
Taenia crassiceps and Taenia solium larvae. We find that the larvae of both species contain
substantial acetylcholinesterase activity. However, acetylcholinesterase activity is lower in
Taenia solium as compared to Taenia crassiceps larvae. Further, whilst we observed acetyl-
cholinesterase activity in all fractions of Taenia crassiceps larvae, including on the mem-
brane surface and in the excreted/secreted extracts, we could not identify
acetylcholinesterases on the membrane surface or in the excreted/secreted extracts of Tae-
nia solium larvae. Bioinformatic analysis revealed conservation of the functional protein
domains in the Taenia solium acetylcholinesterases, when compared to the homologous
human sequence. Finally, using whole-cell patch clamp recordings in rat hippocampal brain
slice cultures, we demonstrate that Taenia larval derived acetylcholinesterases can break
down acetylcholine at a concentration which induces changes in neuronal signalling.
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Together, these findings highlight the possibility that Taenia larval acetylcholinesterases
can interfere with cholinergic signalling in the host, potentially contributing to pathogenesis
in neurocysticercosis.
Author summary
Infection of the human nervous system with larvae of the parasite Taenia solium is a sig-
nificant cause of acquired epilepsy worldwide. Despite this, the precise cellular and molec-
ular mechanisms underlying epileptogenesis in neurocysticercosis remain unclear.
Acetylcholinesterases are a family of enzymes widely produced by helminthic parasites.
These enzymes facilitate the breakdown of acetylcholine, which is also a major neuro-
transmitter in the human nervous system. If T. solium larvae produce acetylcholinester-
ases, this could potentially disrupt host cholinergic signalling, which may in turn
contribute to seizures and epilepsy. We therefore set out to investigate the presence and
activity of acetylcholinesterases in T. solium larvae, as well as in Taenia crassiceps larvae, a
species commonly used as a model parasite in neurocysticercosis research. We found that
both T. crassiceps and T. solium larvae produce acetylcholinesterases with substantial
activity and that the functional protein domains in the Taenia solium acetylcholinesterases
have great similarity to those of human acetylcholinesterases. We further demonstrate
that the acetylcholinesterase activity in the products of these parasites is sufficient to break
down acetylcholine at a concentration which induces changes in neuronal signalling in an
ex vivo brain slice model. This study provides evidence that Taenia larvae produce acetyl-
cholinesterases and that these can potentially interfere with cholinergic signalling in the
host and contribute to pathogenesis in neurocysticercosis.
Introduction
Neurocysticercosis is a human disease which arises when larvae of the cestode Taenia solium
(T. Solium) infect the central nervous system [1]. The most common symptom of this infection
is the development of epileptic seizures, which occur in 70–90% of symptomatic neurocysticer-
cosis cases [2]. As a result, neurocysticercosis is a major cause of adult-acquired epilepsy
worldwide. Neurocysticercosis impacts heavily on the quality of life of those infected, and is
also a significant drain on the medical and economic resources of endemic countries [3–5].
Despite the global impact of neurocysticercosis, precisely how cerebral infection with T. solium
relates to the development of seizures remains unclear.
It has been well documented that many parasitic worms of the alimentary tract produce
substances that aid them in modulating host responses in ways that benefit the parasite [6–8].
Acetylcholinesterases (AChEs), which catalyse the breakdown of acetylcholine, are one family
of enzymes that have been implicated in the modulation of host responses. Helminths widely
express membrane-bound forms of AChEs, which are classically associated with the facilita-
tion of rapid acetylcholine signalling to parasite muscle, sensory, and neural structures [9,10].
Some also produce surface-presenting membrane-bound AChEs [11–14], or can actively
excrete/secrete AChEs, which may modulate acetylcholine dependent components of the host
immune response, play a role in detoxification of ingested cholinesterase inhibitors, or inhibit
smooth muscle contraction and mucus and fluid secretion associated with clearance of intesti-
nal parasites [10,15–17].
PLOS NEGLECTED TROPICAL DISEASES Acetylcholinesterase activity in Taenia larvae
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008966 December 21, 2020 2 / 21
\190829): a partnership between the African
Academy of Sciences and the Royal Society funded
by the UK Government’s Global Challenges
Research Fund. UFP, CS and CPdC were supported
by the Federal Ministry of Education and Research
of Germany (BMBF), Project title: “CYSTINET-
Africa” (01KA1610, Germany II). AdL received
financial support from the National Research
Foundation (110743), the Oppenheimer Memorial
Trust (20787/02) and the University of Cape Town
(Doctoral Research Scholarship). BH is supported
by a BBSRC grant: BB/R015856/1, a Royal Society
International Exchange grant: IES\R1\180108, a
LeStudium-Marie Curie Fellowship and a NRF (SA)
Competitive Support for Rated Researchers grant:
111815. The funders had no role in study design,
data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Acetylcholine is also a major neurotransmitter in the human brain, with powerful
effects on the excitability of cortical circuits [18,19]. It is a critical component of multiple
brain systems that are responsible for functions such as attention, learning, memory, sleep
and motor activity [20,21]. Disruption of cholinergic signalling is well known to lead to sei-
zures. For instance, mutations of the nicotinic acetylcholine receptor (in the genes coding
for the β4 or α2 subunits) underlie a heritable form of epilepsy called autosomal dominant
nocturnal frontal lobe epilepsy [22]. The mutant receptors are more sensitive to acetylcho-
line than normal receptors, and may generate seizures by promoting and synchronizing
spontaneous oscillations in thalamo-cortical circuits [22]. Further, pilocarpine (an acetyl-
choline muscarinic receptor agonist) is a well described proconvulsant agent [23] and the
blockade of endogenous brain AChEs by organophosphate pesticides or poisons can also
cause seizures [24,25].
Since T. solium larvae invade the central nervous system in neurocysticercosis, it is impor-
tant to determine potential AChE activity expressed by these larvae, as such activity could con-
ceivably interfere with endogenous cholinergic signalling in the brain by breaking
acetylcholine down into neurologically inactive products [26]. Taenia crassiceps (T. crassiceps)
is a related cestode, which has also been known to invade the human nervous system, and is
widely utilised as a model parasite for T. solium in animal models of cysticercosis and neuro-
cysticercosis [27–29]. It is therefore also important to ascertain how AChE activity might com-
pare between the larvae of these two Taenia species.
AChEs have been reported in the adult forms of several members of the broader Taeniidae
family [30–32] as well as in larval stages [9,11,13,33,34]. The AChEs are often associated with
the neural structures and parasite tegument of Taeniids, and there is also some suggestion that
some Taeniid larvae may release AChEs into the host environment [33]. Studies describing
cholinesterases in T. crassiceps larvae are scarce, with one report of AChEs in the bladder wall
of T. crassiceps [35], and one other study which refers to the presence of “unidentified ester-
ases” in the cystic fluid of T. crassiceps [36].
The genome of T. solium has recently been sequenced [37] and bioinformatics have
revealed three T. solium acetylcholinesterase homologs [16]. Whether the acetylcholinesterases
are expressed during the larval stage of T. solium, and if so, what their activities and locations
are, is not yet clear. A histological study by Vasantha et al. [38] in T. solium larvae demon-
strated AChE staining in neural structures of the larvae. No obvious staining of AChEs on the
surface of the larvae is described, apart from positive staining in a few surface nerve endings.
We further found one other report of cholinesterase activity in T. solium larvae, with activity
predominantly present in the isolated cyst bladder ([39] cited in [40]).
Therefore, there is an important need for a detailed characterization of AChE activity in the
larvae of different Taenia species, as well as an investigation into whether larval derived
AChEs could conceivably disrupt host neuronal cholinergic signalling. Here, we used multiple
techniques to explore AChEs activity in different extracts of both T. crassiceps and T. solium
larvae. We find that both the larvae of T. crassiceps and T. solium contain significant AChE
activity, but it is broadly lower in T. solium as compared to T. crassiceps larvae. In addition,
whilst AChEs were present in all fractions of T. crassiceps larvae, including the membrane sur-
face and excreted/secreted extracts, we could not identify AChEs on the membrane surface or
within the excreted/secreted extracts of T. solium larvae. Using bioinformatic approaches we
show that functional protein domains in the Taenia solium acetylcholinesterases are con-
served, when compared to the homologous human sequence. Finally, using whole-cell patch
clamp recordings in rodent hippocampal brain slice cultures we demonstrate that Taenia larval
derived AChEs can break down acetylcholine at a concentration which induces changes in
neuronal signalling.
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Materials and methods
Ethics statement
All animal handling, care and procedures were carried out in accordance with South African
national guidelines (South African National Standard: The care and use of animals for scien-
tific purposes, 2008) and with approval from the University of Cape Town Animal Ethics
Committee (Protocol No: AEC 019/025, AEC 014/035).
Bioinformatics
The protein sequences for T. solium and T. saginata cholinesterase homologues, identified in
Tedla et al. [16], were downloaded from https://parasite.wormbase.org/ (Accession numbers:
TsM_000001700 [Tso1], TsM_000234300 [Tso2], TsM_001220100 [Tso3],
TSAs00071g07627m00001 [Tsa]). The human protein sequence was downloaded from NCBI
(Accession number NP000656 [Hs]). Protein sequences were aligned using ClustalW in Snap-
Gene (v5.5.5) and the presented alignment prepared with BOXSHADE (https://embnet.vital-
it.ch/software/BOX_form.html). Annotations of protein domains were based on those in
Tedla et al. [16]. The percent identity matrix for the analysed protein sequences was generated
using Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/).
Taenia acquisition, maintenance, and preparation of cyst extracts
Acquisition and maintenance of T. crassiceps larvae. Larvae (ORF strain) were donated
by Dr Siddhartha Mahanty (University of Melbourne, Melbourne, Australia) and propagated
in vivo by serial intraperitoneal infection of 5-8-week-old female C57BL/6 mice. Every 3
months parasites were harvested by peritoneal lavage and washed 6 times in phosphate buff-
ered saline (PBS, 1X, pH 7.4) before further processing.
Preparation of T. crassiceps whole cyst homogenate. Larvae were frozen at -80˚C imme-
diately after harvesting. Upon thawing, larvae were suspended in a volume of PBS threefold that
of the larvae. A protease inhibitor cocktail was added to this suspension (1% vol/vol, Sigma-
Aldrich). The larvae were then homogenised on ice using a glass tissue grinder. The resulting
mixture was centrifuged at 3100 g for 20 minutes at 4˚C. The liquid supernatant (excluding the
low density white floating layer) was collected and sterile filtered through a 0.22 μm size filter
(Millex-GV syringe filter, Merck). This supernatant was then aliquoted and stored at -80˚C
until use. This preparation is referred to as “T. crassiceps whole cyst homogenate”.
Preparation of T. crassiceps cyst membrane and cyst vesicular fluid extracts. After har-
vesting, washed larvae (+/- 10ml) were placed onto a piece of filter paper (which had been satu-
rated with 1X PBS) in a metal sieve. Cysts were then ruptured using a weighing spatula. The fluid
from the ruptured cysts that passed through the filter paper was collected in a beaker and was cen-
trifuged at 3100 g for 20 minutes at 4˚C, and the supernatant was collected, aliquoted and stored
at -80˚C until use. This extract is referred to as “T. crassiceps cyst vesicular fluid”. The fraction of
the cysts that remained on the filter paper were scraped off with the weighing spatula and sus-
pended in an equal volume of PBS containing a protease inhibitor cocktail (1% vol/vol, Sigma-
Aldrich). This mixture was freeze-thawed once at -80˚C, homogenised on ice using a glass tissue
grinder, and centrifuged at 3100 g for 20 minutes at 4˚C. The liquid supernatant was collected, ali-
quoted, and stored at -80˚C until use. This extract is referred to as “T. crassiceps cyst membrane”.
Preparation of T. crassiceps larval excretory/secretory extracts. After harvesting,
washed larvae (+/- 10 ml) were placed in a 50 ml culture flask with 10 ml culture medium (Ear-
le’s Balanced Salt Solution with 5.3 g/L glucose, 1X Glutamax, 50 U/ml penicillin, 50 μg/ml
streptomycin, 100 μg/ml gentamicin sulphate and 11.4 U/ml nystatin). Larvae were
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maintained at 37˚C in 5% CO2. After 48 hrs the medium was discarded and replaced with 10
ml fresh media. At 20 days in vitro (at which point larvae still displayed motility) the culture
media was collected, aliquoted, and stored at -80˚C until use. For electrophysiology experi-
ments the excretory/secretory extracts were dialysed/buffer exchanged with PBS using an Ami-
con stirred cell (Merck) with a 3 kDa molecular weight cut-off membrane, in order to remove
small molecules that could potentially induce electrophysiological responses that would inter-
fere with the acetylcholine effect (such as glutamate—see [41].
Acquisition of T. solium larvae. Larvae of T. solium were harvested from the muscles of a
heavily infected, freshly slaughtered pig in Lusaka, Zambia. Larvae were removed from the
muscle by vigorous shaking and collected in petri dishes containing sterile PBS (1X, pH 7.4).
Preparation of T. solium whole cyst homogenate. After extensive washing with sterile
PBS (1X, pH 7.4), larvae were suspended in a volume of PBS threefold that of the larvae, con-
taining phenylmethyl-sulphonyl fluoride (5 mM) and leupeptin (2.5 μM). Larvae were then
homogenised using a sterile handheld homogenizer at 4˚C. The resulting homogenate was
sonicated (4 x 60 s at 20 kHz, 1 mA, with 30 s intervals), gently stirred with a magnetic stirrer
(2 hrs at 4˚C), and centrifuged at 15 000 g for 60 min at 4˚C. The liquid supernatant (excluding
the low density white floating layer) was collected and sterile filtered through 0.45 μm size fil-
ters (Millex-GV syringe filter, Merck). This supernatant was then collected, aliquoted and
stored at -80˚C until use. This preparation is referred to as “T. solium whole cyst homogenate”.
Preparation of T. solium cyst vesicular fluid extracts and cyst membrane and scolex.
After extensive washing with sterile PBS, larvae were placed in a petri dish and individually
ruptured with a sterile needle. The resulting fluid in the petri dish was collected and centri-
fuged at 15 000 g for 60 min at 4˚C. The supernatant was then sonicated (4 x 60 s at 20 kHz, 1
mA, with 30 s intervals), phenylmethyl-sulphonyl fluoride (5 mM) and leupeptin (2.5 μM)
were added, and the solution was centrifuged a second time at 15,000 g for 60 min at 4˚C. The
supernatant was collected, aliquoted and stored at -80˚C until use. This extract is referred to as
“T. solium cyst vesicular fluid”. The remaining parts of the larvae were again extensively
washed with PBS and then suspended in an equal volume of PBS containing phenylmethyl-sul-
phonyl fluoride (5 mM) and leupeptin (2.5 μM). This suspension was again homogenised
using a sterile handheld homogenizer at 4˚C. The resulting homogenate was sonicated (4 x 60
s at 20 kHz, 1 mA, with 30 s intervals), gently stirred with a magnetic stirrer (2h at 4˚C), and
centrifuged at 15,000 g for 60 min at 4˚C. The liquid supernatant (excluding the low density
white floating layer) was collected and sterile filtered through 0.45 μm size filters (Millex-GV
syringe filter, Merck). This supernatant was then aliquoted and stored at -80˚C until use. This
extract is referred to as “T. solium cyst membrane and scolex”.
Preparation of T. solium excretory/secretory extracts. After harvesting, washed larvae
were placed into 6 well plates (+/- 15 per well) with 2 ml culture medium (RPMI 1640 with 10
mM HEPES buffer, 100 U/ml penicillin, 100 μg/ml streptomycin, 0.25 μg/ml amphotericin B
and 2 mM L-glutamine). Every 24 h, 1 ml of culture medium was collected from each well and
replaced with fresh culture medium. Medium from all wells was pooled each day, aliquoted
and stored at -80˚C. Media collected on days 1, 2, and 3 in vitro were pooled, and are referred
to as “T. solium excretory/secretory extracts”.
All T. crassiceps and T. solium larval extracts were assessed for protein concentration using
a BCA or Bradford protein assay kit (Sigma-Aldrich), respectively.
Acetylcholinesterase activity and inhibitor sensitivity
AChE activity was determined by the method of Ellman et al. [42] at room temperature with 1
mM acetylthiocholine iodide as substrate in the presence of 1 mM 5,5’-dithiobis(2-nitrobenzoic
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acid) (DTNB) in 100 mM sodium phosphate (pH 7.0). The reaction was monitored by measur-
ing the absorbance at 412 nm, and hydrolysis of acetylthiocholine iodide calculated from the
extinction coefficient of DTNB [42]. Activity was expressed as nanomoles of acetylthiocholine
hydrolysed per minute per milligram of total protein in each larval extract (nmol min-1 mg-1).
To test the sensitivity of Taenia AChEs to different inhibitors, extracts were preincubated with
different concentrations of 1,5-bis(4-allyldimethylammoniumphenyl)pentan-3-one dibromide
(BW 284c51), tetraisopropyl pyrophosphoramide (iso-OMPA) or eserine salicylate for 20 min
at room temperature in Ellman buffer, prior to the addition of 1 mM acetylthiocholine iodide
and enzyme activity determination. Each reaction was assayed a minimum of three times.
Where AChE activity was reduced to undetectable levels by inhibitors, a residual activity of 0%
was allocated on inhibition curves.
Non-denaturing polyacrylamide gel electrophoresis (PAGE)
Extracts were electrophoresed in Tris-glycine buffer, pH 8.3, through 7.5% polyacrylamide gels
in the absence of denaturing and reducing agents. Electrophoresis was performed at 150 V for 3
hrs on ice. Protein staining (Coomassie) was performed on one set of PAGE gels, and specific
staining for AChE activity was performed overnight as described by Selkirk and Hussein [43]
adapted from the method of Karnovsky and Roots [44]. The maximum volume of each protein
extract was loaded (20 μl), to ensure maximal staining. Protein concentrations of the different
extracts varied (T. crassiceps: whole cyst homogenate = 1.9 mg/ml, cyst membrane = 3.4 mg/ml,
cyst vesicular fluid = 3.0 mg/ml and excretory/secretory extracts = 1.32 mg/ml; T. solium: all
extracts = 1.5 mg/ml). AChE stains were performed at least three times to ensure reproducibility.
In situ localisation of acetylcholinesterases
To localise Taenia AChEs, Taenia larvae were submerged in 10% formalin for 60 min, to fix
the tissue. Some of the larvae were then stained overnight for AChE activity as described by
Selkirk and Hussein [43], and mounted onto slides as whole mounts. A subset of the fixed lar-
vae was embedded in cryo-embedding medium, frozen overnight at -80˚C, and cryo-sectioned
the following day at 50 μm. The sections were then similarly stained overnight for AChE activ-
ity, placed on positively charged slides and dehydrated in graded alcohols before mounting. To
assess non-specific staining, in a subset of the whole mount and cryo-section specimens, acet-
ylthiocholine iodide (the substrate) was omitted during the AChE staining procedure. Speci-
mens were imaged using an upright light microscope.
An ex vivo model to examine the effect of Taenia AChEs in the context of
neurocysticercosis
Hippocampal brain slice preparation. Organotypic brain slices were prepared using 6-
8-day-old Wistar rats following the protocol originally described by Stoppini et al. [45]. Briefly,
brains were extracted and swiftly placed in cold (4˚C) dissection media consisting of Earle’s Bal-
anced Salt Solution (Sigma-Aldrich) supplemented with D-glucose (6.1 g/L) and HEPES (6.6 g/
L). The hemispheres were separated, and individual hippocampi were removed and immedi-
ately cut into 350 μm slices using a Mcllwain tissue chopper (Mickle). Cold dissection media
was used to separate and rinse the slices before placing them onto Millicell-CM membranes
(Sigma-Aldrich). Slices were maintained in culture medium consisting of 25% (vol/vol) Earle’s
balanced salt solution; 49% (vol/vol) minimum essential medium (Sigma-Aldrich); 25% (vol/
vol) heat-inactivated horse serum (Sigma-Aldrich); 1% (vol/vol) B27 (Invitrogen, Life Technol-
ogies) and 6.2 g/l D-glucose (Sigma-Aldrich). Slices were incubated in a 5% carbon dioxide
(CO2), humidified incubator at 37˚C. Recordings were made after 6–14 days in culture.
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Electrophysiology. Brain slices were transferred to a submerged recording chamber on a
patch clamp rig, which was maintained at a temperature between 28 and 34˚C, and were con-
tinuously superfused with standard artificial cerebrospinal fluid (120 mM NaCl, 3mM KCl, 2
mM MgCl2, 2 mM CaCl2, 1.2 mM NaH2PO4, 23 mM NaHCO3 and 11 mM D-Glucose in deio-
nised water with pH adjusted to between 7.35–7.40 using 0.1 mM NaOH) bubbled with carbo-
gen gas (95% O2: 5% CO2) using peristaltic pumps (Watson-Marlow). Micropipettes were
prepared (tip resistance between 3 and 7 MO) from borosilicate glass capillaries (outer diame-
ter 1.2 mm, inner diameter 0.69 mm) (Harvard Apparatus Ltd) using a horizontal puller (Sut-
ter). Micropipettes utilised for whole cell patch clamping were filled with an artificial cell
internal solution (126 mM K-gluconate, 4 mM KCl, 10 mM HEPES, 4 mM Na2ATP, 0.3 mM
NaGTP and 10 mM Na2-phosphocreatine) before being placed over the recording electrode.
Neurons in the CA3 region of the hippocampus were visualized using an upright micro-
scope with a 20X water immersion objective. Surface cells with a typical pyramidal cell body
morphology were selected for whole cell patching. To explore the ability of Taenia acetylcho-
linesterase activity to alter neuronal acetylcholine signalling, two additional “puffer” micropi-
pettes were lowered to the cell surface once a neuron had been patched. One of these
micropipettes contained a solution of 200 μm acetylcholine with 1.3 mg/ml T. crassiceps excre-
tory/secretory extracts, while the second contained a solution of 200 μm acetylcholine with 1.3
mg/ml T. crassiceps excretory/secretory extracts that had been heated to 56˚C for 30 min to
inactivate enzymes. Current was injected to hold the membrane potential of cells close to their
action potential firing threshold. Five 30 ms puffs (~20 psi) of one of the solutions was then
applied to the cell’s surface using an OpenSpritzer [46] and the neuron’s response recorded for
26 s before a 94 s “recovery” period was allowed. Thereafter an identical puff train of the other
solution was applied, and the neuron’s response again recorded for 26 s. After another 94 s
recovery period, the cycle was repeated.
Post-recording analysis consisted of counting the number of action potentials induced by
the application of each solution within a 5 s period of the onset of the puff train. Only traces
with a baseline membrane potential prior to the puff application of between -60 mV and -45
mV were included. Each data point in the puffing experiments represents the average of
between 2 and 5 repeats of the puff cycle. Matlab (MathWorks) was utilised for trace analysis.
Data analysis and statistics
Data was visualised and analysed using Matlab, Microsoft Excel and GraphPad Prism. Each
dataset was subjected to a Shapiro-Wilk test to determine whether it was normally distributed.
Most datasets proved to be non-normal and as such non-parametric analyses were utilised
throughout. These included: Kruskal-Wallis analyses with Dunn’s multiple comparison post-
hoc tests and Mann-Whitney tests. The confidence interval for all tests was set at 95%.
Results
All T. crassiceps larval extracts display acetylcholinesterase activity
In order to quantify AChE activity in T. crassiceps larvae, Ellman’s assays were employed,
using acetylthiocholine as a substrate [42]. These assays revealed that all T. crassiceps larval
extracts had significant AChE activity (Table 1 and Fig 1A). A Kruskal Wallis one-way
ANOVA with post hoc Dunn’s Multiple Comparison tests revealed that the only statistically
significant difference between the median activities of the different T. crassiceps larval extracts
was between that of the cyst vesicular fluid and that of the excretory/secretory extracts
(P� 0.01, Fig 1A).
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To visually confirm T. crassiceps AChE activity, and to assess whether there may be more
than one AChE isoform in T. crassiceps larval extracts, non-denaturing PAGE gels were run,
and stained for AChE. A second set of non-denaturing PAGE gels were run simultaneously
and Coomassie stained. These demonstrated that the different T. crassiceps larval extracts con-
tained different protein compositions (left tracks in Fig 1B). The AChE stained gels (right
track for each larval extract in Fig 1B) showed distinct dark bands (indicated by black arrow-
heads) in the tracks of all the T. crassiceps larval extracts, thereby confirming that all the T.
crassiceps larval extracts show AChE activity. In the whole cyst homogenate and the cyst mem-
brane tracks of the AChE stained gels, there was an additional smaller band (indicated by the
red arrowheads in Fig 1B). These results suggest that T. crassiceps larvae express more than
one isoform of AChE.
Inhibitor sensitivity of T. crassiceps larval acetylcholinesterases
The sensitivity of AChE activity in T. crassiceps larval extracts to different inhibitors was tested
by preincubating them for 20 min with different concentrations of BW 284c51 (a selective
AChE inhibitor), iso-OMPA (a selective butyryl cholinesterase inhibitor) or eserine salicylate
(a nonselective cholinesterase inhibitor) before assaying AChE activity [42]. All T. crassiceps
extracts showed a similar dose-dependent inhibitory response to BW 284c51, with AChE activ-
ity in all extracts being almost completely inhibited by the presence of 1000 μM BW 284c51
(Fig 1C and S1 Table). Conversely, the AChE activity of T. crassiceps extracts was not greatly
inhibited by iso-OMPA, with only very small reductions in activity being observed even at
high (1 mM) inhibitor concentration (Fig 1C and S1 Table). AChE activity in T. crassiceps
cyst membrane, cyst vesicular fluid and excretory/secretory extracts was highly sensitive to
eserine inhibition, with strong inhibition apparent at low (1 μM) eserine concentration (Fig
1C and S1 Table). The AChE activity of T. crassiceps whole cyst homogenate was less sensitive
to eserine inhibition, only displaying strong inhibition at a much higher eserine concentration
(100 μM) (Fig 1C and S1 Table). These inhibition patterns suggest that the cholinesterase pro-
duced by T. crassiceps larvae can be classified as true AChEs, as opposed to pseudocholinester-
ases [47].
T. crassiceps acetylcholinesterases are ubiquitous within the tegument
membrane and are present on the larval surface
To spatially localise AChEs within the larvae, both cross-sections of larvae and whole larvae
were subjected to AChE staining [44], (Fig 1D). To evaluate non-specific staining, a second set
of larval cross-sections and whole larvae were subjected to the same staining procedure, with
the exception that the substrate (acetylthiocholine iodide) was omitted. Samples where the
Table 1. Acetylcholinesterase (AChE) activity of different larval extracts of T. crassiceps and T. solium.
Larval species Larval extract # of assays Median AChE activity (nmol min-1 mg-1)
Whole cyst homogenate 10 31.7 (IQR 24.0–58.3)
Taenia crassiceps Cyst membrane 10 39.7 (IQR 36.1–46.3)
Cyst vesicular fluid 10 51.5 (IQR 50.9–54.1)
Excretory/secretory extracts 10 31.8 (IQR 50.9–54.1)
Whole cyst homogenate 5 4.1 (IQR 4.1–5.1)
Taenia solium Cyst membrane & scolex 5 14.0 (IQR 13.8–15.3)
Cyst vesicular fluid 5 4.7 (IQR 3.37–5.03)
Excretory/secretory extracts 4 Undetectable
https://doi.org/10.1371/journal.pntd.0008966.t001
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Fig 1. Identification and characterisation of acetylcholinesterases in Taenia crassiceps larval extracts. A) Quantification of
acetylcholinesterase (AChE) activity in different Taenia crassiceps larval extracts. AChE activity was quantified using the method of
Ellman et al. [42] with 1 mM acetylthiocholine iodide as substrate in the presence of 1 mM 5,5’-dithiobis(2-nitrobenzoic acid) in 100
mM sodium phosphate, pH 7.0, at room temperature. The extracts assessed were: whole cyst homogenate (Hom); cyst membrane
(CM), cyst vesicular fluid (CVF) and larval excretory/secretory extracts (ES). Values with median ± IQR, N = 10 for all extracts assayed,
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substrate was omitted (top panels, Fig 1D) showed minimal staining. In contrast, cross sec-
tions stained for AChE activity displayed dense, uniform staining, indicating that AChEs are
localised ubiquitously throughout the tegument membrane (bottom-left panel, Fig 1D).
Whole larvae stained for AChE revealed that staining localised to numerous small protrusions
on the surface of the cyst tegument membrane (bottom-right panel, Fig 1D).
T. solium larvae produce acetylcholinesterases but do not actively excrete/
secrete them
Next, we focussed on the major pathogenic cestode of humans; T. solium. Ellman’s assays
revealed that T. solium whole cyst homogenate, cyst membrane and scolex, and cyst vesicular
fluid had detectable AChE activity, whilst the excretory/secretory extracts consistently dis-
played no detectable AChE activity (Table 1 and Fig 2A). A Kruskal Wallis one-way ANOVA
with post hoc Dunn’s Multiple Comparison tests revealed that the cyst membrane and scolex
had a statistically significantly higher activity than that of the whole cyst homogenate and the
cyst vesicular fluid, whilst the median activity of two latter extracts did not differ significantly
from one another (P� 0.01, Fig 2A).
To visually confirm AChE activity in T. solium, and to assess whether there may be more
than one AChE isoform in larval extracts, non-denaturing PAGE gels were resolved and
stained for AChE (Fig 2B). Again, a second set of non-denaturing PAGE gels were run simul-
taneously and Coomassie stained. The Coomassie stain showed that each extract has a distinct
protein profile composition (left tracks in Fig 2B). The AChE stained gels (right track for each
larval extract in Fig 1B) revealed bands in the whole cyst homogenate and in the cyst mem-
brane and scolex preparations (indicated by black arrowheads), but no apparent band in the
cyst vesicular fluid track. The absence of bands in the cyst vesicular fluid tract, and the rela-
tively faint bands in tracks of the other extracts can be attributed to the fact that the amount
and concentrations of the extracts loaded contain a drastically lower total AChE activity than
is usually recommended for this technique [43]. In future investigations this could be solved
by concentration or purification of the AChEs in T. solium extracts.
Inhibitor sensitivity of T. solium larval acetylcholinesterases
The sensitivity of AChE activity in T. solium larval extracts to different inhibitors was tested by
preincubating them for 20 min with different concentrations of BW 284c51, iso-OMPA or
eserine salicylate, before assaying AChE activity [42]. All T. solium extracts showed a similar
dose-dependent inhibitory response to BW 284c51, although the T. solium whole cyst homoge-
nate appears somewhat less sensitive to inhibition than the cyst membrane and scolex and cyst
vesicular fluid (Fig 2C and S2 Table). T. solium extracts showed low sensitivity to inhibition
��p� 0.01, Kruskal-Wallis test with Dunn’s multiple comparison post-hoc tests B) Non-denaturing polyacrylamide gel electrophoresis
of Taenia crassiceps extracts. Extracts were electrophoresed in Tris-glycine buffer, pH 8.3, through 7.5% polyacrylamide gels in the
absence of denaturing and reducing agents. Coomassie staining was performed on one set of gels (left tracks), and staining for AChE
activity [44] was performed on another set of gels for 16 hrs after incubation with the substrate (right tracks). The maximum volume of
each extract was loaded (20 μl), to ensure maximal staining. Protein concentrations of the different extracts varied: Hom = 1.9 mg ml-1,
CM = 3.4 mg ml-1, CVF = 3.0 mg ml-1 and ES = 1.32 mg ml-1. C) Inhibitor sensitivity of Taenia crassiceps AChEs. Taenia crassiceps
extracts were preincubated with BW 284C51, iso-OMPA or eserine salicylate (Eserine) for 20 min at room temperature in Ellman
buffer, prior to the addition of 1 mM acetylthiocholine iodide and enzyme activity determination. Median ± Range, N = 10 for all
extracts in absence of inhibitors, N = 3 for all extracts at all inhibitor concentrations. D) Localisation of larval AChEs. Cryo-sections
(N = 19 for control and N = 19 for AChE stain) and whole mounts (N = 15 for control and N = 15 for AChE stain) of Taenia crassiceps
larvae were subjected to AChE staining [44] for 16 hrs prior to dehydration and mounting. Images in top panels show time-matched
controls where acetylthiocholine iodide was omitted from the staining solution. Cross sections were imaged at 5X magnification and
whole mounts were imaged at 100X magnification.
https://doi.org/10.1371/journal.pntd.0008966.g001
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Fig 2. Identification and characterisation of acetylcholinesterases in Taenia solium extracts. A) Quantification of
acetylcholinesterase (AChE) activity in different Taenia solium extracts as in Fig 1. The extracts assessed were: whole cyst
homogenate (Hom); cyst membrane and scolex (CMS), cyst vesicular fluid (CVF) and larval excretory/secretory extracts (ES). Values
with median ± IQR, N = 5 for all extracts assayed, ��p� 0.01, Kruskal-Wallis test with Dunn’s multiple comparison post-hoc tests.
UD = undetectable. B) Non-denaturing polyacrylamide gel electrophoresis of different Taenia solium extracts. Coomassie staining
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by iso-OMPA (Fig 2C and S2 Table). T. solium whole cyst homogenate, cyst membrane and
scolex, and cyst vesicular fluid showed very variable sensitivities to inhibition by increasing
concentrations of eserine, but were ultimately all strongly inhibited at an eserine concentration
of 1 mM or less (Fig 2C and S2 Table). These inhibition patterns suggest that the cholinester-
ases produced by T. solium larvae can be classified as true AChEs, as opposed to pseudocholin-
esterases [47].
T. solium larval acetylcholinesterases are localised within the cyst tegument
membrane, but do not appear to present on the surface of the parasite
Next, we set out to spatially localise AChEs within the larvae. To do so both cross-sections of
larvae and whole larvae were subjected to the same AChE staining as was applied to T. crassi-
ceps larvae. Control samples where the substrate was omitted to evaluate non-specific staining
(top panels, Fig 2D), showed some patchy black background staining. AChE stained cross-sec-
tions showed uniform, although not very dense, AChE staining throughout the tegument
membrane (in addition to the black background staining) (bottom-left panel, Fig 2D). High
magnification images of the surface of the tegument membrane in whole-mounted AChE-
stained larvae revealed that, unlike in T. crassiceps, AChEs in the tegument membrane of T.
solium are not surface-presenting (bottom-right panel, Fig 2D).
Homology of Taenia solium, Taenia saginata and Homo sapiens
acetylcholinesterases
Given that the genome for T. solium and the related species Taenia saginata (T. saginata)
are available (the genome for T. crassiceps has not yet been sequenced), we performed
amino acid sequence alignments to determine the putative structural resemblance between
host (Homo sapiens) and parasite acetylcholinesterase enzymes. The analysis of full amino
acid sequence alignments for T. solium, T. saginata and Homo sapiens (H. sapiens) acetyl-
cholinesterases (Fig 3) revealed the percent identity between the acetylcholinesterase of T.
saginata (TSa_s00071g07627m00001) and one of the T. solium acetylcholinesterase
sequences (Ts_000234300) to be 97%, whilst there was only a 33% and 38% identity between
the acetylcholinesterase of T. saginata and the other two T. solium acetylcholinesterase
sequences (Ts_000001700 and Ts_001220100, respectively). The percent identity between
the three different T. solium acetylcholinesterase sequences ranged from 33% to 38%, and
the percent identity of these to the of H. sapiens acetylcholinesterase (Hs_NP_000656) simi-
larly ranged from 36% to 39%. Importantly, the “catalytic triad”, which has been described
to form the active site for ester hydrolysis within the enzyme, is fully conserved between H.
sapiens and two of the three T. solium acetylcholinesterase amino acid sequences (TsM
000001700 [Tso1], and TsM 001220100 [Tso3], yellow boxes in Fig 3), while three of the
four sites that form the “acyl binding pocket”, a region of the enzyme that confers substrate
specificity, are fully conserved across all the analysed sequences (green boxes in Fig 3)
was performed on one set of PAGE gels (left tracks), and staining for AChE activity [44] was performed on another set of gels (right
tracks). For each extract, 30 μg of total protein was loaded. C) Inhibitor sensitivity of Taenia solium AChEs. Taenia solium extracts
were preincubated with BW 284C51, iso-OMPA or eserine salicylate (Eserine) for 20 min at room temperature in Ellman buffer,
prior to the addition of 1 mM acetylthiocholine iodide and enzyme activity determination. Median ± Range, N = 5 for all extracts in
absence of inhibitors and at 10 μM inhibitor concentration, N = 3 for all extracts at all other inhibitor concentrations. D) Localisation
of larval AChEs. Cryo-sections (N = 20 for control and N = 20 for AChE stain) and whole mounts (N = 4 for control and N = 4 for
AChE stain) of Taenia solium larvae were subjected to AChE staining [44]. Images in top row show time-matched controls where
acetylthiocholine iodide was omitted from the staining solution. Cross sections were imaged at 5X magnification and whole mounts
were imaged at 40X magnification.
https://doi.org/10.1371/journal.pntd.0008966.g002
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Fig 3. Full amino acid sequence alignment for Taenia solium, Taenia saginata and Homo sapiens acetylcholinesterase proteins. (Accession
numbers: NP000656 [Hs], TsM_000001700 [Tso1], TsM_000234300 [Tso2], TsM_001220100 [Tso3], TSAs00071g07627m00001 [Tsa]). The catalytic
triad is indicated in yellow and the acyl binding pocket is indicated in green.
https://doi.org/10.1371/journal.pntd.0008966.g003
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[16,48]. These findings support our earlier findings that T. solium contains cholinesterases
and that these are true acetylcholinesterases, as opposed to pseudocholinesterases.
Larvae of T. solium have less acetylcholinesterase activity as compared to T.
crassiceps, and T. crassiceps larvae excrete/secrete acetylcholinesterases,
whilst T. solium larvae do not
Comparison of AChE activity in the extracts of T. crassiceps versus the comparable T. solium
extracts show that T. solium extracts consistently have significantly lower AChE activities than
those of T. crassiceps (P� 0.001, Mann Whitney tests, Table 1). Further, a different pattern of
AChE distribution within the cyst is observed between the two species–T. solium AChEs appear
to be predominantly located in the cyst membrane and scolex, whilst T. crassiceps AChEs appear
abundant in both the cyst membrane and in the cyst vesicular fluid and are additionally excreted/
secreted (Table 1). T. crassiceps also displays surface presenting AChEs, whilst T. solium do not, as
revealed by AChE staining of whole larvae (Figs 1D and 2D). It is also noteworthy that T. crassi-
ceps and T. solium larval extracts display different inhibitor sensitivities to BW 284c51, iso-OMPA
and particularly to eserine (Fig 1C versus Fig 2C). This suggests that the two parasites produce
different forms of AChE, although further investigation would be required to confirm this.
Taenia larval acetylcholinesterases have sufficient activity to break down
acetylcholine at a concentration which induces changes in neuronal
signalling in an ex vivo brain slice model
In order to investigate what implications the presence of Taenia larval AChEs may have in the
context of neurocysticercosis, 200 μM acetylcholine (known to induce depolarisation in hippo-
campal pyramidal neurons [49]) was applied to neurons in hippocampal organotypic cultures,
together with either heat-inactivated T. crassiceps excretory/secretory products, or active T.
crassiceps excretory/secretory products. The response of the membrane potential of the neu-
rons was measured using whole-cell patch-clamp recordings (see Materials and Methods, and
Fig 4A and 4B). When neurons were held at a voltage close to their action potential threshold
and picolitre volumes of 200 μM acetylcholine with heat-inactivated excretory/secretory prod-
ucts were puffed toward the soma of the neurons, they depolarised and fired action potentials
(APs) (median = 3.6 APs, IQR = 1.0–11.2 APs, N = 16, Fig 4B and 4C). However, when
200 μM acetylcholine with active excretory/secretory products were applied to the same neu-
rons just 2 min prior to/after this, the neurons did not show the same response, often firing no
action potentials despite still being held at a voltage close to their action potential threshold
(median = 0.2 APs, IQR = 0.0–1.7 APs, N = 16, P = 0.0017, Wilcoxon signed-rank test, Fig
4C). Whilst this formally only demonstrates that a heat-labile component of the extract has an
inhibitory effect, this is highly likely due to AChEs in the T. crassiceps larval excretory/secre-
tory products. These experiments therefore indicate that T. crassiceps larval excretory/secre-
tory products have sufficient AChE activity to break down acetylcholine at a concentration
which induces changes in neuronal signalling in this ex vivo brain slice model. This would
hold true for T. solium cyst membrane and scolex AChEs, given twice the amount of time, or
the use of an extract of double the concentration, as these break down acetylcholine at roughly
half the rate of T. crassiceps larval excretory/secretory extracts (Table 1).
Discussion
Here we have used multiple methods to characterise the amount and spatial localization of
AChE activity in larvae of the cestodes T. crassiceps and T. solium. Previous studies have
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Fig 4. Taenia acetylcholinesterases can break down acetylcholine at a concentration which induces changes in
neuronal signalling. A) Schematic depicting the experimental setup where whole-cell patch-clamp recordings were
made from rat CA3 pyramidal neurons in organotypic hippocampal brain slice cultures. Whilst recording the electrical
activity from the neurons, two glass pipettes delivered picolitre volumes of acetylcholine (ACh) (200 μM) with heat-
inactivated (at 56˚C for 30 min) Taenia crassiceps excretory/secretory extracts (1.3 mg ml-1), or of ACh (200 μM) with
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identified AChE activities in the larvae of multiple species of the broader Taeniidae family
including Echinococcus granulosus (dog tapeworm) [30,33,34] and Taenia pisiformis (rabbit
tapeworm) [13]. To our knowledge our data represent the first definitive measurements of
AChE activity from larvae of T. crassiceps. The amount of AChE activity we report in T. crassi-
ceps whole cyst homogenate is similar to that previously reported for the larval homogenate of
T. pisiformis (T. crassiceps whole cyst homogenate median activity = 31.69 nmol min-1 mg-1, T.
pisiformis homogenate mean activity = 24.8 nmol min-1 mg-1) [13]. Interestingly we found that
whilst T. solium larvae also exhibit substantial AChE activity, this activity is broadly less than
in extracts from T. crassiceps. Furthermore, the spatial profile of larval AChE activity is differ-
ent between these two species. Whilst AChEs were present in all fractions of T. crassiceps lar-
vae, and presented on the tegument membrane surface, we could not identify AChEs on the
tegument membrane surface or within the excreted/secreted extracts of T. solium larvae. The
lack of surface staining in T. solium larvae is in accordance with a previous study by Vasantha
et al. (1992), which reports AChEs in T. solium larvae to be associated with a sub-tegumental
network of nerves in the strobila and bladder wall.
Our findings have important implications in the context of T. crassiceps being utilised as a
model organism for neurocysticercosis research, where both larval extracts and whole early-
stage cysts of T. crassiceps have been employed [50–53]. Our data illustrate that there exist sig-
nificant differences in the cholinergic biology of T. solium and species that have been utilised
as model parasite for T. solium, such as T. crassiceps. Once the genome for T. crassiceps has
been sequenced, future work will also be able to determine potential differences in AChE
amino-acid sequences between cestode species. Notably, the reported AChE activity of tetra-
thyridia of Mesocestoides corti, another popular model parasite for neurocysticercosis research,
is far greater than that which we report for both T. crassiceps and T. solium [54]. These differ-
ences should be considered when selecting an appropriate model parasite for NCC research.
Our observation that T. solium larvae do not excrete/secrete AChEs is interesting, as many
helminth species have been observed to secrete these enzymes in substantial amounts, with
proposed benefits to parasite survival, such as protection against ingested AChE inhibitors and
modulation of the host immune response [7,10,16]. Recently, a study by Vaux et al. (2016)
demonstrated that in vivo exposure to secreted AChE from Nippostrongylus brasiliensis pro-
moted classical activation of macrophages (as opposed to alternative activation), a state which
is permissive to the survival of parasitic nematodes. In contrast, classically activated macro-
phages appear to be deleterious to the survival of Taeniid larvae, occurring in the resistant Th1
acute phase of infection, whilst their phenotype is shifted to an alternatively activated state dur-
ing chronic Taeniid infection [8,55]. This could potentially explain why it may not be benefi-
cial for Taeniids to secrete large amounts of AChE.
Our bioinformatics analysis demonstrated that there was modest overall sequence identity
between T. solium and H. sapiens acetylcholinesterase sequences, as has been previously
reported for Schistosoma mansoni [16]. However, the fact that protein functional domains
appear to be conserved between T. Solium and H. sapiens lends support to our experimental
findings that Taenia larvae contain active AChEs. In addition, using whole-cell patch clamp
unheated/active Taenia crassiceps excretory/secretory extracts (1.3 mg ml-1). B) The membrane potential responses of a
pyramidal neuron when a solution of ACh with heat-inactivated (HI) Taenia crassiceps excretory/secretory extracts
(ES) (top trace) or of ACh with active Taenia crassiceps ES (bottom trace) was puffed onto the cell body (arrowheads
indicate moment of application). C) Population data (median ± IQR) where each point represents the mean number of
action potentials evoked in 5 s after neurons were exposed to 5 x 30 ms puffs (2–5 repeat cycles) of either a solution of
ACh with HI Taenia crassiceps ES (N = 13) or of ACh with active Taenia crassiceps ES (N = 13). ��p� 0.01, Wilcoxon
signed-rank test.
https://doi.org/10.1371/journal.pntd.0008966.g004
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recordings in rodent hippocampal brain slice cultures, we show that Taenia larval-derived
AChEs have sufficient activity to break down acetylcholine at a concentration which induces
changes in neuronal signalling. These experiments demonstrate that although the activities of
Taenia larval-derived AChEs may not seem substantial when compared to that of other para-
sitic worms, such as Nippostrongylus brasiliensis (which has a reported excretory/secretory
extract AChE activity of 5.3 μmol min-1 mg-1 [56]), they may well be substantial enough to
exert an effect in the sensitive brain environment. It should also be taken into consideration
that in clinical presentations of NCC, T. solium larvae interface directly with brain tissue,
which means that the membrane-bound AChEs in T. solium larvae identified in this study
could potentially have a direct and spatially concentrated impact on brain tissue when the cyst
starts to degrade and lose membrane integrity. Although we have demonstrated in this study
that larval-derived AChEs have sufficient activity to break down acetylcholine at a concentra-
tion which induces changes in neuronal signalling in an ex vivo brain slice model, further
electrophysiological investigations, preferably using purified T. solium AChE applied in an in
vivo model, are required to determine whether the activity of larval-derived AChEs can, in
fact, functionally alter neuronal signalling.
The cause of seizures and epilepsy secondary to neurocysticercosis has been a matter of great
controversy, with some researchers questioning whether neurocysticercosis is truly causative of
epilepsy, and with different studies sometimes reporting contrasting results [57–59]. One thing
that has become increasingly clear in recent years, however, is that inflammation is closely
linked to the generation of seizures and epilepsy, both generally, and within the context of neu-
rocysticercosis [60,61]. In the healthy brain, microglia and astrocytes regulate inflammatory sig-
nalling in the brain via, amongst others, acetylcholine receptor dependent signalling [62].
Activation of acetylcholine receptors has been shown to strikingly impair acute phase inflam-
mation [63,64]. One might hypothesise, then, that exposure of the brain to T. solium membrane
AChEs during cyst degeneration could exacerbate perilesional inflammation if the larval AChEs
break down acetylcholine molecules involved in anti-inflammatory signalling. Based on this
supposition, future investigations involving the addition of AChE inhibitors to NCC model sys-
tems that present with severe perilesional inflammation, could be of potential value.
In summary, our findings describe distinct profiles of acetylcholinesterase activity in T.
crassiceps and T. solium larvae. In light of this, we encourage neurocysticercosis researchers to
take into consideration that differences do exist between T. solium and related cestodes such as
T. crassiceps. We also highlight the possibility of larval-derived acetylcholinesterases interfering
with host neural and immune signalling in the brain.
Supporting information
S1 Table. Sensitivity of cholinesterase activity of T. crassiceps extracts to different inhibi-
tors. Legend: UD = undetectable, where activity was so low as to be undetectable.
(TIF)
S2 Table. Sensitivity of cholinesterase activity of T. solium extracts to different inhibitors.
Legend: UD = undetectable, where activity was so low as to be undetectable.
(TIF)
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